S022 Alopecia Areata: New Therapies
DESCRIPTION
With the current interest in hair loss conditions being on the rise, it is important to understand alopecia areata as it is the most common cause of immune- mediated alopecia, affecting 2% of the USA population. The intricate pathology, patients demographics and comorbidities, and the new therapeutic options will be discussed. The team of speakers have been leaders in developing alopecia areata severity scale and therapeutic guidelines.
LEARNING OBJECTIVES
Compare and analyze novel therapies for alopecia areata
Identify patients who are eligible for novel medications considering their comorbidities
Describe therapeutic guidelines for alopecia areata, including dosing, duration of treatment and clinical prognosis
SCHEDULE
1:00 PM
Current state of alopecia areata
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
1:10 PM
Alopecia areata: diagnostic pearls
Chesahna Kindred, MD, MBA, FAAD
1:30 PM
Adults with Alopecia Areata: My treatment approach
Maryanne Makredes Senna, MD, FAAD
1:50 PM
The World of JAK inhibitors
Brett Andrew King, MD, PhD, FAAD
2:10 PM
How to treat children with Alopecia areata?
Brittany Gareth Craiglow, MD, FAAD
2:30 PM
Do I use any procedures for areata treatment?
Jerry Shapiro, MD, FAAD
2:45 PM
Burning QUESTIONS
3:00 PM
My Top 3 Pearls for Alopecia Areata
Wilma Fowler Bergfeld, MD, FAAD
3:15 PM
Dermoscopy Tips to Recognize Areata
Bruna Duque-Estrada, MD
3:25 PM
AA therapy: Global Perspective
Rodrigo Pirmez, MD
3:40 PM
JAK inhibitors and Young women
Tina Bhutani, MD, FAAD
3:55 PM
LAST QUESTIONS
DIRECTOR
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
SPEAKERS
Wilma Fowler Bergfeld, MD, FAAD
Tina Bhutani, MD, FAAD
Brittany Gareth Craiglow, MD, FAAD
Bruna Duque-Estrada, MD
Chesahna Kindred, MD, MBA, FAAD
Brett Andrew King, MD, PhD, FAAD
Maryanne Makredes Senna, MD, FAAD
Rodrigo Pirmez, MD
Jerry Shapiro, MD, FAAD
HANDOUTS
DISCLOSURES
Wilma Fowler Bergfeld, MD, FAAD
No financial relationships exist with ineligible companies.
Tina Bhutani, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Amgen – Investigator(Grants/Research Funding), Speaker(Honoraria); Apogee BioPharm – Advisory Board(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Arcutis, Inc. – Advisory Board(Fees); ASLAN Pharmaceuticals – Data Safety Monitoring Board(Fees), Data Safety Monitoring Board(Honoraria); Boehringer Ingelheim – Advisory Board(Fees); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Castle Biosciences – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Clementia Pharmaceuticals – Investigator(Grants/Research Funding); CoreEvitas, LLC – Investigator(Grants/Research Funding); Dermatology Foundation – Speaker(Honoraria); Dermavant Sciences – Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Fees); FIDE – Consultant(Fees); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); Happify – Consultant(Fees); Incyte – Advisory Board(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Fees); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); LearnSkin – Speaker(Honoraria); Leo Pharma – Speaker(Honoraria); LEO Pharma, US – Advisory Board(Fees); Mindera – Investigator(Grants/Research Funding), Speaker(Honoraria); National Psoriasis Foundation – Speaker(Honoraria); Novartis – Advisory Board(Fees), Investigator(Grants/Research Funding); Ortho Dermatologics – Speaker(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Taxa – Consultant (1099 relationship)(Stock); UCB – Advisory Board(Fees), Speaker(Honoraria);
Brittany Gareth Craiglow, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Speaker(Fees); BiologicsMD, Inc. – Consultant (1099 relationship)(Fees); Concert Pharmaceuticals – Consultant(Grants/Research Funding); CorEvitas – Consultant (1099 relationship)(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Consultant(Fees), Speaker(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte – Advisory Board(Fees); Incyte Corporation – Speaker(Honoraria); Leo Pharma – Advisory Board(Fees); Novartis – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees), Investigator(No Compensation Received), Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees);
Bruna Duque-Estrada, MD
No financial relationships exist with ineligible companies.
Chesahna Kindred, MD, MBA, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Fees); Aerolase – Speaker(Fees); Arcutis Biotherapeutics – Speaker(Fees); Eli Lilly – Investigator(Fees); Factor Medical – Speaker(Fees); Lilly ICOS LLC – Advisory Board(Fees), Speaker/Faculty Education(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Pfizer Inc. – Speaker/Faculty Education(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); UCB – Advisory Board(Fees); Xtresse – Stockholder Private Company(No Compensation Received);
Brett Andrew King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees); GLife – Advisory Board(Stock Options); Inmagene – Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Priovant Therapeutics – Advisory Board(Fees), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Veradermics – Advisory Board(Fees), Advisory Board(Stock);
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); FotoFinder Systems GmbH – Speaker(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); DS Laboratories – Consultant (1099 relationship)(Honoraria); Eirion Therapeutics – Consultant (1099 relationship)(Stock Options); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Veradermics – Consultant (1099 relationship)(Fees), Stockholder Public Company(No Compensation Received);